Friday, May 1, 2026

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

North Korea Continues to Withdraw Diplomatic Offices Abroad

2024 Global Diplomacy Index Report by Lowy...

“NORMAL” OR A DEADLY LIE? The $30 Billion Question: Is Kim’s Uranium Waste Floating Toward Your Kitchen Sink?

South Korea confirms no abnormalities in monitoring for radioactive wastewater from North Korea's uranium plant, ensuring ongoing surveillance.

Tag: Influenza

Moderna secures EU approval for combined influenza-COVID vaccine mCOMIRNATY

Moderna's mCOMIRNATY, a combined COVID-19 and influenza vaccine, gains European approval for adults 50+, enhancing its respiratory portfolio.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Top News

- Our Sponsors Ad -

Follow us